Related Experiment Video

Updated: Jun 30, 2025

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

6.5K

Tumor immune escape by autotaxin: keeping eosinophils at bay

Elisa Matas-Rico1, Wouter H Moolenaar2

  • 1Department of Cell Biology, Genetics and Physiology, University of Málaga, Málaga, Spain.

Trends in Cancer
|March 17, 2024
PubMed

Insights

Secreted autotaxin (ATX) drives tumor growth by producing lysophosphatidic acid (LPA). This signaling pathway blocks eosinophil immune cell entry into pancreatic tumors, promoting cancer progression and revealing a new immune evasion strategy.

Area of Science:

  • Oncology
  • Immunology
  • Biochemistry

Background:

  • Secreted autotaxin (ATX) is an enzyme that generates lysophosphatidic acid (LPA), a lipid mediator implicated in tumor progression.
  • Tumor microenvironments are complex ecosystems influenced by various signaling pathways and immune cells.

Purpose of the Study:

  • To investigate the role of ATX/LPA signaling in regulating immune cell infiltration within the pancreatic tumor microenvironment.
  • To identify novel mechanisms of immune evasion employed by pancreatic tumors.

Main Methods:

  • The study analyzed the interaction between ATX/LPA signaling and eosinophil infiltration in pancreatic tumors.
  • Researchers examined how ATX/LPA signaling influences the tumor microenvironment's immune landscape.

Main Results:

  • ATX/LPA signaling was found to suppress the infiltration of eosinophils, a type of immune cell, into the pancreatic tumor microenvironment.
  • This suppression of eosinophil infiltration facilitates tumor progression by hindering an anti-tumor immune response.

Conclusions:

  • The findings reveal a previously unrecognized mechanism by which ATX/LPA signaling promotes immune escape in pancreatic cancer.
  • Eosinophils demonstrate potential as therapeutic agents against pancreatic tumors, suggesting that targeting ATX/LPA could enhance anti-tumor immunity.

More Related Videos

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

727
Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports07:44

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

7.5K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K